JP2022534709A5 - - Google Patents
Info
- Publication number
- JP2022534709A5 JP2022534709A5 JP2021569992A JP2021569992A JP2022534709A5 JP 2022534709 A5 JP2022534709 A5 JP 2022534709A5 JP 2021569992 A JP2021569992 A JP 2021569992A JP 2021569992 A JP2021569992 A JP 2021569992A JP 2022534709 A5 JP2022534709 A5 JP 2022534709A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- substituted
- alkyl
- alkyls
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962856822P | 2019-06-04 | 2019-06-04 | |
| US62/856,822 | 2019-06-04 | ||
| PCT/US2020/035851 WO2020247447A1 (en) | 2019-06-04 | 2020-06-03 | Pyrazole and imidazole derivatives, compositions and methods as orexin antagonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022534709A JP2022534709A (ja) | 2022-08-03 |
| JP2022534709A5 true JP2022534709A5 (enExample) | 2023-06-08 |
| JP7837120B2 JP7837120B2 (ja) | 2026-03-30 |
Family
ID=73651984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021569992A Active JP7837120B2 (ja) | 2019-06-04 | 2020-06-03 | オレキシンアンタゴニストとしてのピラゾール及びイミダゾール誘導体、組成物、並びに方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20220315602A1 (enExample) |
| EP (1) | EP3972587A4 (enExample) |
| JP (1) | JP7837120B2 (enExample) |
| KR (1) | KR20220016919A (enExample) |
| CN (1) | CN114340616A (enExample) |
| AU (1) | AU2020288559C1 (enExample) |
| CA (1) | CA3140173A1 (enExample) |
| SG (1) | SG11202112828SA (enExample) |
| WO (1) | WO2020247447A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022534704A (ja) | 2019-06-04 | 2022-08-03 | ヘイガー バイオサイエンシズ，エルエルシー | オレキシンアンタゴニストとしてのイミダゾロ誘導体、組成物、及び方法 |
| KR20220119653A (ko) | 2019-12-20 | 2022-08-30 | 테나야 테라퓨틱스, 인코포레이티드 | 플루오로알킬-옥사디아졸 및 이의 용도 |
| US20240252502A1 (en) | 2021-05-04 | 2024-08-01 | Tenaya Therapeutics, Inc. | Hdac6 inhibitors for treatment of metabolic disease and hfpef |
| JP2025530768A (ja) * | 2022-09-01 | 2025-09-17 | ヘイガー バイオサイエンシズ，エルエルシー | 神経疾患および精神疾患の治療のための、オレキシン受容体およびカッパオピオイド受容体に対する二重調節剤としてのピラゾール誘導体およびイミダゾール誘導体、組成物、ならびに治療法 |
| EP4471034A4 (en) * | 2022-11-23 | 2025-06-18 | Jiangsu NHWA Pharmaceutical Co., Ltd | DISUBSTITUTED OCTAHYDROPYRROLO[3,4-C PYRROL METHYL KETONE DERIVATIVE AND ITS USE |
| GB202311281D0 (en) | 2023-07-21 | 2023-09-06 | Bial Portela & Ca Sa | Orexin receptor antagonists |
| GB202311280D0 (en) | 2023-07-21 | 2023-09-06 | Bial Portela & Ca Sa | Orexin receptor antagonists |
| CN117169393B (zh) * | 2023-11-03 | 2024-03-19 | 杭州湃肽生化科技有限公司 | 一种植物组织中环肽的检测方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4925849A (en) * | 1987-06-15 | 1990-05-15 | Fujisawa Pharmaceutical Company, Ltd. | Pharmaceutically useful pyrazolopyridines |
| SI1836211T1 (sl) * | 2004-12-21 | 2010-04-30 | Pfizer Prod Inc | Makrolidi |
| AR067665A1 (es) * | 2007-07-27 | 2009-10-21 | Actelion Pharmaceuticals Ltd | Derivados de trans-3- aza-biciclo ( 3.1.0) hexano |
| EP2630138B1 (en) * | 2010-10-21 | 2015-06-03 | Bayer Intellectual Property GmbH | 1-(heterocyclic carbonyl)-2-substituted pyrrolidines and their use as fungicides |
| EP2730573A4 (en) * | 2011-07-05 | 2014-12-03 | Taisho Pharmaceutical Co Ltd | METHYLPIPERIDINDERIVAT |
| US9242995B2 (en) * | 2011-10-25 | 2016-01-26 | Merck Sharp & Dohme Corp. | Isoxazolopyridine orexin receptor antagonists |
| JP6346862B2 (ja) * | 2012-02-07 | 2018-06-20 | エオラス セラピューティクス， インコーポレイテッド | オレキシンレセプターアンタゴニストとしての置換プロリン／ピペリジン |
| EP3187497A4 (en) * | 2014-08-26 | 2018-02-07 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| MA53721A (fr) * | 2018-09-28 | 2021-09-15 | Janssen Pharmaceutica Nv | Modulateurs de la monoacylglycérol lipase |
| JP2022534704A (ja) * | 2019-06-04 | 2022-08-03 | ヘイガー バイオサイエンシズ，エルエルシー | オレキシンアンタゴニストとしてのイミダゾロ誘導体、組成物、及び方法 |
-
2020
- 2020-06-03 SG SG11202112828SA patent/SG11202112828SA/en unknown
- 2020-06-03 KR KR1020217043401A patent/KR20220016919A/ko not_active Ceased
- 2020-06-03 CN CN202080056013.4A patent/CN114340616A/zh active Pending
- 2020-06-03 JP JP2021569992A patent/JP7837120B2/ja active Active
- 2020-06-03 WO PCT/US2020/035851 patent/WO2020247447A1/en not_active Ceased
- 2020-06-03 US US17/616,142 patent/US20220315602A1/en not_active Abandoned
- 2020-06-03 EP EP20817900.2A patent/EP3972587A4/en not_active Withdrawn
- 2020-06-03 CA CA3140173A patent/CA3140173A1/en active Pending
- 2020-06-03 AU AU2020288559A patent/AU2020288559C1/en not_active Expired - Fee Related
-
2024
- 2024-08-09 US US18/799,706 patent/US12275744B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022534704A5 (enExample) | ||
| JP2022545633A5 (enExample) | ||
| WO2022261383A1 (en) | Novel prodrugs and conjugates of dimethyltryptamine | |
| JPS6084282A (ja) | １−ヘテロアリ−ル−４−〔（２．５−ピロリジンジオン−１−イル）アルキル〕ピペラジン誘導体 | |
| KR101907631B1 (ko) | 1,5-디페닐-펜타-1,4-디엔-3-온 화합물 | |
| CA3076202A1 (en) | Cyclic iminopyrimidine derivatives as kinase inhibitors | |
| PT605228E (pt) | Derivados tiazolidinadionas sua preparacao e sua utilizacao | |
| JP4740116B2 (ja) | 精神疾患および神経障害の処置のための５−ｈｔ受容体アンタゴニスト | |
| HU217590B (hu) | Eljárás 6-os helyen heterociklusos csoporttal helyettesített 4-amino-1,3,4,5-tetrahidro-benz[c,d]indolok és a vegyületeket tartalmazó gyógyszerkészítmények előállítására | |
| BR112020019708A2 (pt) | compostos como moduladores de sinalização de tlr2 | |
| JP2021520415A5 (enExample) | ||
| JP3521214B2 (ja) | ４，５−ジヒドロイソオキサゾリルアルキルピペラジン誘導体とその製造方法並びにドーパミン拮抗剤 | |
| JP2004269469A (ja) | ピリミジン誘導体又はその塩 | |
| EP4633625A2 (en) | Prodrugs of dimethyltryptamine and derivatives thereof | |
| JP6542236B2 (ja) | 有機化合物 | |
| HU199825B (en) | Process for production of new derivatives of pirasoline and medical compositions containing them | |
| JPH01168677A (ja) | 向精神性非環式アミド誘導体 | |
| JP6100755B2 (ja) | （２−ヘテロアリールアミノ）コハク酸誘導体 | |
| EP1678159A2 (fr) | Derives de thiophene-2-carboxamide et leurs utilisation comme antagonistes des recepteurs cb1 des cannabinoides | |
| JPS62120374A (ja) | １，３−チアジンまたは１，３−オキサジン誘導体 | |
| CN121673261A (zh) | 哌啶二酮类化合物、及其药物组合物和用途 | |
| JP2017516824A5 (enExample) | ||
| FR2899899A1 (fr) | Derives d'aminomethyl pyridine, leur preparation et leur application en therapeutique | |
| Dyachenko et al. | Multicomponent Synthesis of Nicotinamide and Thieno [2, 3-b] pyridine Derivatives | |
| JP3042915B2 (ja) | ３−（１ｈ−インダゾール−３−イル）−４−ピリジンアミンおよびその製造法 |